Publications (32) Publications de MIGUEL MARTI CABRERA

2024

  1. Treatment of recurrent aphthous stomatitis with oral roflumilast, a multicenter observational study

    International Journal of Dermatology

2022

  1. Gold Nanoparticles Supported on Ceria Nanoparticles Modulate Leukocyte–Endothelium Cell Interactions and Inflammation in Type 2 Diabetes

    Antioxidants, Vol. 11, Núm. 11

  2. Mitochondrial redox impairment and enhanced autophagy in peripheral blood mononuclear cells from type 1 diabetic patients

    Redox Biology, Vol. 58

2021

  1. Micrornas and oxidative stress: An intriguing crosstalk to be exploited in the management of type 2 diabetes

    Antioxidants, Vol. 10, Núm. 5

2020

  1. Leukocyte–Endothelium Interaction Is Associated with Fat Mass in Children

    Journal of Pediatrics, Vol. 221, pp. 181-187.e1

  2. Microbiota-mitochondria inter-talk: A potential therapeutic strategy in obesity and type 2 diabetes

    Antioxidants, Vol. 9, Núm. 9, pp. 1-21

2014

  1. Farmacología de la secreción gastrointestinal y de la ulceración mucosa digestiva

    Farmacología humana (Elsevier), pp. 708-722

  2. Neuronal bioenergetics and acute mitochondrial dysfunction: A clue to understanding the central nervous system side effects of efavirenz

    Journal of Infectious Diseases, Vol. 210, Núm. 9, pp. 1385-1395

  3. Role of endothelial nitric oxide in pulmonary and systemic arteries during hypoxia

    Nitric Oxide - Biology and Chemistry, Vol. 37, Núm. 1, pp. 17-27

2012

  1. Differential effects of tenofovir/emtricitabine and abacavir/lamivudine on human leukocyte recruitment

    Antiviral Therapy, Vol. 17, Núm. 8, pp. 1615-1619

  2. Metabolomics of the effect of AMPK activation by AICAR on human umbilical vein endothelial cells

    International Journal of Molecular Medicine, Vol. 29, Núm. 1, pp. 88-94

  3. Profile of stress and toxicity gene expression in human hepatic cells treated with Efavirenz

    Antiviral Research, Vol. 94, Núm. 3, pp. 232-241

2011

  1. ¿Es real el riesgo de osteoporosis y riesgo de fracturas con el uso crónico de inhibidores de la bomba de protones?

    Gastroenterologia y Hepatologia, Vol. 34, Núm. 4, pp. 271-277

2010

  1. Is the vagina an adequate route for the administration of hormonal contraceptives?

    Current Drug Metabolism, Vol. 11, Núm. 10, pp. 839-849

  2. Seguridad e interacciones de los inhibidores de la bomba de protones: Lecciones aprendidas en millones de pacientes

    Gastroenterologia y Hepatologia, Vol. 33, Núm. SUPPL. 1, pp. 15-21

2006

  1. Seguridad de la utilización de los inhibidores de la bomba de protones

    Medicina Clinica, Vol. 127, Núm. 20, pp. 790-795

2003

  1. Low endotoxemia prevents the reduction of gastric blood flow induced by NSAIDs: Role of nitric oxide

    British Journal of Pharmacology, Vol. 139, Núm. 2, pp. 263-270

1999

  1. Bronchodilator and anti-inflammatory activities of glaucine: In vitro studies in human airway smooth muscle and polymorphonuclear leukocytes

    British Journal of Pharmacology, Vol. 127, Núm. 7, pp. 1641-1651

  2. Contraction of human airways by oxidative stress protection by N- acetylcysteine

    Free Radical Biology and Medicine, Vol. 27, Núm. 3-4, pp. 392-400

1997

  1. Characterization of 5-HT receptors on human pulmonary artery and vein: Functional and binding studies

    British Journal of Pharmacology, Vol. 122, Núm. 7, pp. 1455-1463